anonymous
Guest
anonymous
Guest
Now digest that!
https://www.bloomberg.com/news/arti...a-plans-to-start-developing-its-own-medicines
Is he kidding here?
"Shanghvi says, the company can pursue opportunities more nimbly than rivals weighed down by corporate bureaucracy. “The advantage is that I have end-to-end understanding of all aspects of the business,” he says. “It’s easier for me to take decisions involving risk, because I am able to assess risk from multiple dimensions. In a big company they will need 8 or 10 people who have to look at it.”
https://www.bloomberg.com/news/arti...a-plans-to-start-developing-its-own-medicines
Is he kidding here?
"Shanghvi says, the company can pursue opportunities more nimbly than rivals weighed down by corporate bureaucracy. “The advantage is that I have end-to-end understanding of all aspects of the business,” he says. “It’s easier for me to take decisions involving risk, because I am able to assess risk from multiple dimensions. In a big company they will need 8 or 10 people who have to look at it.”